MID-VOLUME · HOSP-HEAVY

mometasone Side Effects

mometasone (also sold as Asmanex) sits MID-VOLUME #256 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 31.1% mention hospitalization (5,350 reports). Demographics and serious-outcome tables follow.

Data updated 2026-05-15

17,186
FAERS reports

FDA Adverse Event Reporting System extract for mometasone. Stamp set WATCHLIST · DEATH-MARKED · HOSP-HEAVY. How figures are compiled.

mometasone: 31.1% mention hospitalization (5,350 reports). Death stamp DEATH-MARKED; volume band MID-VOLUME #256 of 524 by FAERS report count.

Mid-book FAERS page for mometasone (Asmanex) (17,186 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.

Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-MARKED · HOSP-HEAVY · SEX-BALANCED.

DYSPNOEA leads 1,730 of 17,186 reports

DYSPNOEA
1,730
ASTHMA
1,553
HEADACHE
1,393
COUGH
1,178
FATIGUE
1,098
WHEEZING
966
GASTROOESOPHAGEAL REFLUX DISEASE
965
PRURITUS
905
NAUSEA
892
PAIN
818
PNEUMONIA
804
RASH
761
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
740
DIARRHOEA
720
DIZZINESS
685
ARTHRALGIA
675
HYPERSENSITIVITY
654
MALAISE
654

Who reports · age peak 45-64 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 9,620 (62%)
Male 5,818 (38%)
Unknown 13

Age peak 45-64 (4,126 reports)

0-17 893 (8%)
18-44 2,275 (19%)
45-64 4,126 (35%)
65-74 2,383 (20%)
75+ 2,102 (18%)

FAERS filings rising toward 2025

2004 2025

Reactions in Death Reports

Death appears on 814 reports (4.7% - MARKED). Reactions below co-occur in those rows only.

Reaction Reports
DEATH 287
PNEUMONIA 83
DYSPNOEA 80
HYPERSENSITIVITY 58
GENERAL PHYSICAL HEALTH DETERIORATION 54
CARDIAC DISORDER 53
FATIGUE 52
PLEURAL EFFUSION 51
WEIGHT DECREASED 50
ASTHENIA 48
FALL 45
RESPIRATORY FAILURE 41
DIARRHOEA 40
ANAEMIA 38
OEDEMA PERIPHERAL 36
SEPSIS 36
COUGH 34
ERYTHEMA 34

Reactions in Hospitalization Reports

Hospitalization is HEAVY (5,350, 31.1% of the book). Top reactions in those rows:

Reaction Reports
DYSPNOEA 921
ASTHMA 767
PNEUMONIA 581
GASTROOESOPHAGEAL REFLUX DISEASE 557
HEADACHE 539
WHEEZING 536
COUGH 461
FATIGUE 420
PYREXIA 409
HYPERTENSION 399
THERAPEUTIC PRODUCT EFFECT INCOMPLETE 392
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 369
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 364
NAUSEA 327
CARDIAC DISORDER 311
PAIN 308
DIARRHOEA 302
ASTHENIA 297
How to read mometasone FAERS figures (WATCHLIST · DEATH-MARKED · HOSP-HEAVY)

FAERS holds 17,186 voluntary reports linked to mometasone (Asmanex), 2004-2025. Death is listed on 814 (4.7%). Hospitalization appears on 5,350 (31.1%). Top co-reported indication: Product Used For Unknown Indication.

Mid-volume extract - treat DEATH-MARKED · HOSP-HEAVY as signal-detection rates next to 31.1% mention hospitalization (5,350 reports).

Read with mometasone

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-MARKED · HOSP-HEAVY stamps.